High-efficiency viral gene delivery for T lymphocytes engineering using metabolic bioorthogonal strategy
文献类型：会议论文
| 作者 | Fangfang Wang; Yutong Han; Yingmei Luo; Lintao Cai; Yifan Ma; Hong Pan |
| 出版日期 | 2018 |
| 会议日期 | 2018 |
| 会议地点 | 上海 |
| 英文摘要 | Engineered T cells have been used as treatment for tumors which shows promising clinical results. However, the outcomes have yet been tempered by the manufacturing process due to low delivery efficiency of exogenous gene. Herein, we utilized glycometabolic labeling and bioorthogonal chemistry to establish a highly efficient viral transduction system for human primary T lymphocytes. we synthesized and optimized DBCO-PEG4-NHS conjugated PEI1.8K (PEI-DBCO), and utilized the glycometabolic labeling to incorporate azide groups onto the surface of T cells by administration with azide-conjugated glucose Ac4GlcNAz. PEI-DBCO packaged viruses were facilitated to the azide-labeled T cell infection via bioorthogonal targeting, and rising the lentiviral infection efficiency up to 80% without damping T cell activities. In particularly, PEI-DBCO facilitated viral transduction system significantly increased amount of CD19 specific CAR T cells, and enhanced anti-tumor cytokine secretion. Administration of CAR T cells prepared by PEI-DBCO facilitated viral transduction system exerted better curative effects in the humanized B lymphoma bearing mice, comparing with those mice treated with conventional manufactured CAR T cells both in vitro and in vivo. This novel cell gene delivery technique based on glycometabolic bioorthogonal chemistry, displays powerful capability in engineering of primary T lymphocytes, especially in the clinical CAR T cell manufacture and immunotherapy. |
| 语种 | 英语 |
| 源URL | [http://ir.siat.ac.cn:8080/handle/172644/14748]  |
| 专题 | 深圳先进技术研究院_医药所 |
| 推荐引用方式 GB/T 7714 | Fangfang Wang,Yutong Han,Yingmei Luo,et al. High-efficiency viral gene delivery for T lymphocytes engineering using metabolic bioorthogonal strategy[C]. 见:. 上海. 2018. |
入库方式： OAI收割
来源：深圳先进技术研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。